Staubitz-Vernazza Julia I, Lederer Ann-Kathrin, Bouzakri Nabila, Lozan Oana, Wild Florian, Musholt Thomas J
Section of Endocrine Surgery, Department of General, Visceral and Transplantation Surgery, University Medical Center, Johannes Gutenberg University Mainz, Langenbeckstraße 1, D-55131, Mainz, Germany.
Langenbecks Arch Surg. 2024 Dec 5;409(1):373. doi: 10.1007/s00423-024-03556-w.
Postoperative hypoparathyroidism (HypoPT) is one of the most feared complications after thyroid surgery. In most cases, HypoPT is transient, requiring temporary substitution with calcium and active vitamin D. The analysis was conducted to investigate how calcium and vitamin D substitution was managed in routine postoperative clinical practice after discharge from hospital.
From March 2015 to December 2023, patients with HypoPT after thyroidectomy at the university medical center (UMC) Mainz, were included in a retrospective study. The rate of continued prescription of calcium and vitamin D by external practitioners in relation to the PTH and calcium levels at the first postoperative outpatient visit at the outpatient clinic of the UMC Mainz was analyzed and critically discussed.
Ninety-four of 332 patients (28.3%) were continuously prescribed with calcium/vitamin D supplements: 14 had PTH deficiency and hypocalcemia and 14 had normal/elevated PTH levels with hypocalcemia, 59 had PTH values below the normal range and normo- or hypercalcemia and 7 had normal or elevated PTH levels with normocalcemia.
There are inconsistent procedures regarding the adjustment of the calcium and vitamin D substitution by the practices providing external follow-up treatment. To avoid iatrogenic suppression of PTH levels, high calcium load and potential affection of the kidney function, a reduction scheme should be actively recommended by thyroid surgeons.
术后甲状旁腺功能减退(HypoPT)是甲状腺手术后最令人担忧的并发症之一。在大多数情况下,HypoPT是暂时的,需要用钙和活性维生素D进行临时替代治疗。本分析旨在研究出院后常规术后临床实践中钙和维生素D替代治疗是如何管理的。
2015年3月至2023年12月,美因茨大学医学中心(UMC)行甲状腺切除术后发生HypoPT的患者纳入一项回顾性研究。分析并批判性地讨论了外部执业医生根据美因茨大学医学中心门诊术后首次门诊就诊时的甲状旁腺激素(PTH)和钙水平持续开具钙和维生素D处方的情况。
332例患者中有94例(28.3%)持续接受钙/维生素D补充剂治疗:14例存在PTH缺乏和低钙血症,14例PTH水平正常/升高但伴有低钙血症,59例PTH值低于正常范围且血钙正常或升高,7例PTH水平正常或升高且血钙正常。
提供外部随访治疗的机构在调整钙和维生素D替代治疗方面的程序不一致。为避免医源性抑制PTH水平、高钙负荷以及对肾功能的潜在影响,甲状腺外科医生应积极推荐一种减量方案。